Fresh Recalls

FDAClass II · Drug · Recall D-0582-2026 · Recalled June 17, 2026

Duloxetine Delayed-Release Capsules recall — Breckenridge Pharmaceutical, Inc.

Agency report date: June 17, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Duloxetine Delayed-Release Capsules
Company / brand
Breckenridge Pharmaceutical
Lot / serial / date codes
Lot: 241180C, Exp. Date April 2027.
Distribution
Nationwide within the United States
Agency product description and boundaries

Duloxetine Delayed-Release Capsules, USP, 30mg, 1000 Capsule bottles, Rx only, Manufactured. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Duloxetine Delayed-Release Capsules

3. Open the official notice or contact

Official recall ID
D-0582-2026
Brand
Breckenridge Pharmaceutical
Classification
Class II
Units affected
14,729 bottles.
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Berkeley Heights, NJ, United States
Firm address
200 Connell Dr Ste 4200, N/A, 07922-2805

Identifying details (verbatim from the notice)

Product codes / lots
Lot: 241180C, Exp. Date April 2027.
Distribution
Nationwide within the United States
Firm notified the public via
Letter
FDA event ID
99108
Recall initiated
June 4, 2026
FDA classified
June 8, 2026
FDA report date
June 17, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page